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Objective: To investigate the mechanism of mechanical stress-induced expression and regulation of aggre-
canases and examine the role of runt-related transcription factor 2 (RUNX-2) in chondrocyte-like cells.
Methods: SW1353 cells were seeded onto stretch chambers at a concentration of 5 104 cells/chamber,
and a uni-axial cyclic tensile strain (CTS) (0.5 Hz, 10% stretch) was applied for 30 min. Total RNA was
extracted, reverse transcribed, and analyzed by polymerase chain reaction (PCR) and real-time PCR.
RUNX-2 overexpression and small interfering RNA (siRNA) targeting RUNX-2 were used to investigate the
role of RUNX-2 in CTS-induced gene expression. The involvement of diverse mitogen-activated protein
kinase (MAPK) pathways in the activation of RUNX-2, MMP-13 and ADAMTS-5 during CTS was examined
by Western blotting.
Results: CTS induced expression of RUNX-2, MMP-13, ADAMTS-4, -5, and -9. Overexpression of RUNX-2
up-regulated expression ofMMP-13 and ADAMTS-5, whereas RUNX-2 siRNA resulted in signiﬁcant down-
regulation of mechanically-induced MMP-13 and ADAMTS-5 expression. CTS induced activation of p38
MAPK, and CTS induction of RUNX-2,MMP-13 and ADAMTS-5mRNAwas down-regulated by the selective
p38 MAPK inhibitor SB203580 but not by the p44/42 MAPK inhibitor U0126, or the JNK MAPK inhibitor
JNK inhibitor II.
Conclusions: RUNX-2 might have a role as a key downstream mediator of p38’s ability to regulate
mechanical stress-induced MMP-13 and ADAMTS-5 expression.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a common joint disease characterized by
cartilage destruction, subchondral bone sclerosis, and osteophyte
formation. The development of OA is related to genetic factors,
environmental factors, metabolic disorders, and biochemical and/or
biomechanical abnormality of the joint. Although mechanical stim-
ulation which represents the physiological environment of cartilage
increases matrix synthetic activity and up-regulates proteinaseeiichiro Nishida, Department
School of Medicine, Dentistry
Okayama 700-8558, Japan.
Nishida).
s Research Society International. Penzymes, repeated excessive mechanical strain may alter chon-
drocyte metabolism and induce structural failure of the extracellular
matrix (ECM)1,2. However, the precise mechanisms of mechanical
stress-induced cartilagematrix degradation are not fully understood.
The main components of the articular cartilage ECM are type II
collagen and aggrecan. Aggrecan loss resulting from decreased
synthesis by chondrocytes and activation of enzymes that degrade
the cartilage matrix is recognized as one of the earliest events in the
course of OA, followed by mechanical injury of collagen ﬁbrils3. OA
disease progression is a highly complicated process involving
multiple events such as aggrecan loss, resulting from decreased
synthesis by chondrocytes and activation of enzymes that degrade
the cartilage matrix. Two classes of enzymes e matrix metal-
loproteinases (MMPs) and aggrecanases e contribute to aggrecan
depletion by cleaving proteins in arthritic cartilage. Various MMPs
play important roles in collagen degradation. MMP-1, -8, -13ublished by Elsevier Ltd. All rights reserved.
Table I
Primer sequences of genes used for RT-PCR and real-time PCR analyses
Gene
name
Primer sequence (50e30) Primer sequence (30e50)
COL2A1 AAT TCC TGG AGC CAA AGG AT AGG ACC AGT TGC ACC TTG AG
RUNX-2 CTC TAC CAC CCC GCT GTC TT CAC CTG CCT GGC TCT TCT TAC
MMP-13 CTT GAT GCC ATT ACC AGT C GGT TGG GAA GTT CTG GCC A
ADAMTS-4 AGG CAC TGG GCT ACT ACT AT GGG ATA GTG ACC ACA TTG TT
ADAMTS-5 TAT GAC AAG TGC GGA GTA TG TTC AGG GCT AAA TAG GCA GT
ADAMTS-9 GGA CAA GCG AAG GAC ATC C ATC CAT CCA TAA TGG CTT CC
G3PDH CAT CAA GAA GGT GGTGAA GCA G CGT CAA AGG TGG AGG AGT GG
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destruction. MMP-1 is expressed in a broad range of normal tissue
types, such as ﬁbroblast and macrophages4. MMP-13 has higher
afﬁnity for type II collagen than MMP-1 or -8 but can also cleave
aggrecan at speciﬁc sites5. Although having less catalytic efﬁciency
than the classic collagenase, MMP-14 has been shown to make the
speciﬁc collagen cleavage6. In the current study,we focused onMMP-
13, of which close relationship with runt-related transcription factor
(RUNX)-2 has been reported previously7.
Aggrecanase-1 and -2 belong to the ADAMTS (a disintegrin and
metalloproteinase with thrombospondin type 1 motifs) family of
zinc metalloproteinases8,9. ADAMTS-1, -8, and -9 have weak
aggrecan degrading activity10e12, whereas ADAMTS-4 (aggreca-
nase-1) and -5 (aggrecanase-2) are known to be efﬁcient cleavers of
aggrecan in vitro and have been implicated in the structural damage
seen in human OA. Which of the ADAMTSs is the primary aggre-
canase responsible for aggrecan degradation in OA has been
intensively investigated13e18, but has not yet reached the general
consensus in human OA. Elucidation of the mechanisms by which
ADAMTSs are activated in OA has important implications for drug
design. Previous reports and our recent report suggest that stim-
ulation by pro-inﬂammatory cytokines such as interleukin (IL)-1
induces expression of ADAMTS-4 and -9 in chondrocytes19,20.
Although mechanical stress-induced aggrecanase expressions have
been clariﬁed partially21,22, overall has not been fully elucidated.
RUNX family members regulate the expression of the genes
involved in cellular differentiation and cell cycle progression. RUNX-2
plays an essential role in bone mineralization (by stimulating osteo-
blastdifferentiation)23. Recent studieshavedemonstrated thatRUNX-
2 contributes to the pathogenesis of OA through chondrocyte
hypertrophy and matrix breakdown after the induction of joint
instability24. In Runx-2-deﬁcient (Runx-2þ/) mice, the pathology of
instability-inducedexperimentalOAwasamelioratedandboth typeX
collagen and MMP-13 expressions were decreased compared with
wild-type mice24. In vitro, cyclic tensile strain (CTS) is known to up-
regulate MMP-13 expression via the Runx-2/Cbfa1 pathway in
primarychondrocytes25. Theseﬁndings ledus to investigate theeffect
of mechanical stress on RUNX-2 expression using SW1353 chon-
drocytes-like cells and the signal transduction pathways underlying
mechanical stress-induced RUNX-2 expression. Our ﬁndings may
contribute to the development of novel disease-modifying anti-OA
drugs targeting the mechanical stress/RUNX-2 pathway.
Methods
Cells and cell culture
SW1353 cells were cultured in 10 mL Dulbecco’s Modiﬁed Eagle
Medium (DMEM, Wako, Osaka, Japan) containing 10% fetal bovine
serum (FBS, HyClone, South Logan, UT), 100 U/mL penicillin, and
100 mg/mL streptomycin (Sigma, Tokyo, Japan) at 37C in
a humidiﬁed atmosphere of 5% CO2 in air. The cells were sub-
cultured at split ratios of 1:3e1:4 using trypsin plus ethyl-
enediaminetetraacetic acid (EDTA) every 7e10 days. The medium
was changed every 3 days. For most experiments, SW1353 cells
were transferred to serum-free DMEM for 24 h before being
exposed to the different stimuli.
Stretching experiments
SW1353 cells were seeded onto stretch chambers, each having
a culture surface of 2 2 cm, at a concentration of 5104 cells/
chamber. The silicon chamber has a 200 mm-thick transparent
bottom and the side wall is 400 mm thick to prevent narrowing of
the bottom center. One end of the chamber is ﬁrmly attached toa ﬁxed frame, while the other end is held on a movable frame. The
movable frame is connected to a motor driven shaft. The amplitude
and the frequency of stretch were controlled by a programmable
microcomputer, ST-140 (STREX, Osaka, Japan). Silicon membrane
was uniformly stretched over the whole membrane area and using
this system, we could apply a known, uniform stretch tomost of the
cells26,27. After 48 h culture on stretch chamber, SW1353 cells
increased to 50% conﬂuence. CTS (0.5 Hz, 10% stretch) was applied
for 30 min using ST-140. Unstretched cells cultured on stretch
chambers were used as controls. To test the effect of 5% and 10% CTS
(0.5 Hz) on anabolic gene expression by SW1353 cells, as the half
life of a1 chain of type II collagen (COL2A1) mRNA is reported to be
approximately 15 h, we examined the COL2A1 expression at 15 and
30 h after CTS by real-time polymerase chain reaction (PCR). Next,
we examined the effect of 10% CTS (0.5 Hz) on RUNX-2,MMP-13 and
ADAMTS-4, -5, -9 expressions by SW1353 cells up to 24 h after CTS
by reverse transcription (RT)-PCR and real-time PCR.
RNA preparation and RT-PCR
Following stimulation, the cells were washed once with phos-
phate buffered saline (PBS), and total RNA was extracted using
ISOGEN (Nippon Gene, Toyama, Japan) reagent according to the
manufacturer’s instructions. Concentration and purity were
assayed with spectrophotometry. One microgram of total RNA was
reverse transcribed to complementary DNA (cDNA) using ReverTra
Ace with Oligo-dT primers according to the manufacturer’s
protocol (TOYOBO, Tokyo, Japan). The cDNAs underwent PCR
ampliﬁcation in the presence of 10 pmol of each speciﬁc primer
using ExTaq DNA polymerase (TAKARA BIO, Shiga, Japan). Each
speciﬁc primer was optimized for concentrations before RT-PCR.
The speciﬁc primer sets described in Table I were used. The cycle
number was selected from the linear part of the ampliﬁcation
curve. For all the RT-PCR fragments, the reactions were allowed to
proceed for 32 cycles for COL2A1, RUNX-2, MMP-13, ADAMTS-5, 31
cycles for ADAMTS-4 and -9, 25 cycles for glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH) in an iCycler thermal cycler (Bio-Rad
Laboratories, Hercules, CA). RT-PCR was performed with incubation
at 94C for 30 s, 60C (55C for RUNX-2) for 30 s, and 72C for 30 s,
with the ﬁnal incubation at 72C for 7 min.
Real-time PCR analyses
Real-time PCR was performed using a LightCycler Rapid Thermal
Cycling system (Roche Diagnostics, Indianapolis, IN), using the
LightCycler-FastStart DNA Master SYBR Green I kit (Roche Diagnos-
tics) according to a previously reported protocol28. The PCR mixture
consisted of 1 SYBR Green PCR Master Mix, which included DNA
polymerase, SYBR Green I dye, dNTPs (including dUTP), PCR buffer,
10 pmol of forward and reverse primers, and cDNA of samples, in
a total volume of 15 mL. Ampliﬁcation of a housekeeping gene,
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Fig. 1. The change of COL2A1 mRNA expression after 5% and 10% mechanical stretch in
SW1353 cells. In real-time PCR (n¼ 6 per experimental group and time point) analyses,
COL2A1 mRNA expression decreased temporarily at 15 h by 10% stretch and returned to
baseline 30 h later. Relative mRNA levels of COL2A1 gene were normalized using G3PDH
controls andplotted relative to CTS () at time0. “Time0” represents the timeﬁnishedCTS.
SW1353 cells were cultured for 30 h after CTS. The datawere presented asmeanwith 95%
CI of triplicate determinations. *P¼ 0.0041 relative to CTS (), **P¼ 0.0459 relative to 5%.
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and the amount of RNA applied. To validate the speciﬁcity of
ampliﬁcation of COL2A1, RUNX-2, MMP-13, ADAMTS-4, -5, -9, and
G3PDH, we sequenced each primer initially, and each speciﬁc primer
was optimized for concentrations before real-time PCR. Real-time
PCR validation was carried out using the 2ΔΔCt method29. Reactions
were performed in triplicate. Gene expression cycle threshold values
were normalized to the expression of the housekeeping geneG3PDH.
Negative controls were obtained with samples in which the RNA
templates were replaced by nuclease-freewater in the reactions. The
intra-assay and inter-assay coefﬁcients of variation were <5% and
were reasonably small compared with those reported in other
studies. Subsequently, the threshold cycle, i.e., the number of cycles
atwhich the amount of the ampliﬁed gene of interest reached a ﬁxed
threshold, was determined.
Overexpression of RUNX-2
We investigated whether overexpression of RUNX-2 regulates
the expression ofMMP-13, ADAMTS-4, -5, and -9. SW1353 cells were
grown to 50% conﬂuence before transfection, according to the
manufacturer’s protocol. Transfection complexes were prepared in
serum-freeDMEMbymixing 0.5 mL of FuGENE6 (RocheDiagnostics)
and 250 ng of RUNX-2 expression plasmid, which was constructed
with a FLAG-tagged pCS2þ vector30. Cells (20% transfection rate of
RUNX-2) were incubated for 24 h, and subsequently subjected to
CTS (0.5 Hz, 10% stretch) for 30 min. RUNX-2 and ADAMTS-5 gene
expressions were examined 1 h after CTS, while the expression of
MMP-13, ADAMTS-4, and -9 was examined 24 h after CTS with
RT-PCR and real-time PCR.
Small interfering RNA (siRNA) construction and transfection
RUNX-2 siRNA assays were performed using Silencer Select Pre-
designed siRNA (Ambion, Austin, TX). SW1353 cells were grown to
30% conﬂuence before transfection, according to the manufacturer’s
protocol. Transfection complexes were prepared in Opti-MEM
serum-free medium (Invitrogen, San Diego, CA) by mixing 1.5 mL of
Oligofectamine (Invitrogen) and 2 mM of siRNA. SW1353 cells were
plated in 24-well format (in stretch chamber for immunocyto-
chemistry) simultaneously with addition of the transfection
complexes. Forty-eight hours after siRNA transfection, cells were
subjected to CTS (0.5 Hz,10% stretch), and subsequently analyzed for
the expression of RUNX-2, MMP-13, ADAMTS-4, -5, and -9 with
RT-PCR, real-time PCR and immunocytochemistry.
Immunocytochemistry
We used immunocytochemistry to observe the expression and
localization of RUNX-2 and ADAMTS-5 induced by CTS at the
protein level. Cells were stretched according to the protocols
described above. One hour after CTS, chambers were ﬁxed with 1%
paraformaldehyde solutions. The chambers were incubated with
anti-RUNX-2 antibody (10 mg/mL, ab76956, Abcam, Cambridge,
UK), anti-MMP-13 antibody (for siRUNX-2 assay, 10 mg/mL, Sigma)
and anti-human ADAMTS-5 antibody (10 mg/mL, R&D Systems,
Minneapolis, MN) for 60 min at room temperature. Bovine serum
albumin-containing solutions without primary antibodies were
used as negative controls. Alexa Fluor 488-conjugated antibody
(10 mg/mL, anti-mouse) was used as secondary antibody, Alexa
Fluor 568-conjugated phalloidin (2 mg/mL) (Invitrogen) for actin
staining, and Hoechst 33342 (1 mg/mL) (ICN Biomedicals, Aurora,
OH) for nuclear staining. Samples were examined under a ﬂuores-
cence microscope (Leica, Wetzlar, Germany).Western blot analysis and protein kinase inhibitor assay
For theWestern blot analysis, SW1353 cells were loadedwith CTS
(0.5 Hz,10% stretch) for 30 min. Onehourafter CTS (15 min for RUNX-
2 and phospho-RUNX-2), cell lysates were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using
a 10% gel and then transferred onto polyvinylidene diﬂuoride
membranes (Bio-Rad Laboratories). Total protein subjected to SDS-
PAGE was 10 mg/lane (15 mg/lane for RUNX-2 and phospho-RUNX-2).
The membranes were blocked with Blocking reagent (TOYOBO) and
incubated overnight at 4C with anti-RUNX-2 (Abnova, Taiwan) and
-p38, -p44/42, -JNK mitogen-activated protein kinase (MAPK)
and anti-phospho-RUNX-2 (Abgent, San Diego, CA) and -p38, -p44/
42, -JNKMAPK antibodies (Cell Signaling Technology, Beverly, MA) at
adilutionof1:1000 (1:100 forphospho-RUNX-2,1:2000 forphospho-
p38) in CanGet Signal Immunoreaction Enhancer Solution (TOYOBO).
The membranes were washed with washing buffer and incubated
with horseradish peroxidase-conjugated anti-mouse secondary
antibody (diluted 1:10,000, R&D Systems) or anti-rabbit secondary
antibody (diluted 1:10,000, Bethyl Laboratories, Montgomery, TX) at
room temperature for 1 h. Immunoreactive proteins were detected
using the ECL Detection System (GE Healthcare, Buckinghamshire,
UK). The densities of obtained Western blotting fragments were
analyzed using Image J software (NIH, Bethesda, MD). The volume of
phosphorylated RUNX-2 andMAPK fragmentwas indicated as a ratio,
which was normalized by the density of each RUNX-2 and MAPK
fragment. For the kinase assays, SW1353 cells were pretreated with
5e50 mMof the speciﬁc inhibitor of p38kinase (SB203580, Santa Cruz
Biotechnology, Santa Cruz, CA), p44/42 kinase (U0126, Calbiochem,
San Diego, CA), JNK kinase (JNK inhibitor II, Calbiochem), or DMSO
alone (as a vehicle control) for 30min and subsequently exposed to
CTS (0.5 Hz,10% stretch) for 30min. The expression levels of RUNX-2,
MMP-13 and ADAMTS-5 were analyzed with real-time PCR analyses.
The stability of G3PDH expression was not changed after protein
kinase inhibitor assay (Supplemental Table 1).
Statistical analysis
All datawere normally distributed and expressed as means with
95% conﬁdence interval (CI). All experiments were repeated at least
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groups were compared using one- or two-way ANOVA with Bon-
ferroni post-hoc test. All differences were considered statistically
signiﬁcant at a P value less than 0.05.
Results
SW1353 cells lost their phenotypic COL2A1 expression after 10% CTS
10% CTS did not affect the cell morphology up to 24 h (data not
shown). Results of MTT assay indicated that 10% CTS did not reduce
the cell viability 24 h after CTS (data not shown). 5% CTS did not
change the expression of the COL2A1 gene at both 15 (P¼ 0.462)
and 30 h (P¼ 0.832), while 10% CTS transiently decreased their
expressions at 15 h (P¼ 0.0041), which returned to baseline within
30 h (P¼ 0.7533) (Fig. 1). These results indicate that 10% CTS had
a catabolic effect in SW1353 cells.Fig. 2. Effects of CTS on RUNX-2, MMP-13 and aggrecanase expressions in SW1353 cells. R
SW1353 cells. Total protein extracts were subjected to PAGE (15 mg of total protein/lane), and
2) antibodies. RT-PCR (B) and real-time PCR (CeG, n¼ 6 per experimental group and time po
of RUNX-2 was up-regulated (B, C). Twenty-four hours after CTS, the expression of MMP-1
ADAMTS-5 gene expression was biphasic (B, F). Relative mRNA levels of each gene were n
represents the time ﬁnished CTS. The data were presented as mean with 95% CI of triplicate d
to CTS (), B¼ CTS (), -¼ CTS (þ).CTS-stimulated MMP-13 and aggrecanase gene expressions in
chondrocyte-like cells
RUNX-2 phosphorylation was detected at 15 min after CTS
[Fig. 2(A)]. Following CTS loading, expression of RUNX-2 increased
up to 4.5 times the levels of unstretched controls after 0.5 h
(P¼<0.0001) [Fig. 2(B) and (C)]. Expression ofMMP-13, ADAMTS-4,
and ADAMTS-9 genes was up-regulated about three fold (MMP-13;
P¼ 0.0002, ADAMTS-4; P¼ 0.0017, ADAMTS-9; P¼<0.0001) [Fig. 2
(B), (D), (E) and (G)]. ADAMTS-5 expression was up-regulated
immediately after CTS (P¼<0.0001), decreased at 3 h (P¼ 0.0975),
and increased at 24 h (P¼<0.0001) [Fig. 2 (B) and (F)].
MMP-13 and ADAMTS-5 gene expression was controlled by RUNX-2
After transfection with RUNX-2, expression of RUNX-2 was
dramatically increased (P¼<0.0001) [Fig. 3(A) and (B)].esults of Western blotting (A) show the RUNX-2 phosphorylation 15 min after CTS in
Western blot analysis was performed with total and phosphorylated RUNX-2 (p-RUNX-
int) analyses were performed using speciﬁc primers. After CTS loading, the expression
3 (B, D), ADAMTS-4 (B, E), and ADAMTS-9 (B, G) was increased. Up-regulation of the
ormalized using G3PDH controls and plotted relative to CTS () at time 0. “Time 0”
eterminations. *P< 0.0001, **P¼ 0.0001, yP¼ 0.0002, zP¼ 0.0009, xP¼ 0.0017 relative
Fig. 3. Effect of RUNX-2 transfection on MMP-13 and aggrecanase mRNA expressions by SW1353 cells with or without CTS. RUNX-2 overexpression-mediated changes in aggre-
canase levels were investigated by RT-PCR (A) and real-time PCR (BeF, n¼ 6 per experimental group) analyses. Mechanical stretch increased the expression of RUNX-2, MMP-13,
ADAMTS-4, -5 and -9 genes in SW1353 cells. The expressions ofMMP-13 (A, C) and ADAMTS-5 (A, E) genes were up-regulated after RUNX-2 transfection. The ADAMTS-4 and -9 genes
were not stimulated by RUNX-2 overexpression (A, D, F). All genes were normalized to G3PDH and plotted relative to CTS (), transfection (). The data were presented as mean
with 95% CI of triplicate determinations. *P< 0.0001, **P¼ 0.0062, yP¼ 0.0001, zP¼ 0.0103, xP¼ 0.0002 relative to TF, (), TF; transfection.
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ADAMTS-5 expression after CTS (MMP-13; P¼ 0.0001, ADAMTS-5;
P¼ 0.0002) [Fig. 3(A), (C) and (E)]. On the other hand, ADAMTS-4
(P¼ 0.5199) and ADAMTS-9 (P¼ 0.071) expression was not inﬂu-
enced by overexpression of RUNX-2 [Fig. 3(A), (D) and (F)]. These
results indicate that RUNX-2 acts as an upstream regulator of MMP-
13 and ADAMTS-5.
CTS-induced MMP-13 and ADAMTS-5 gene expression was inhibited
by siRUNX-2
RUNX-2 siRNA in SW1353 cells decreased RUNX-2 expression by
90% compared with non-transfected cells (P¼<0.0001) [Fig. 4(A)].
RUNX-2 siRNA in SW1353 cells resulted in down-regulation of
MMP-13 (P¼ 0.003) and ADAMTS-5 expression (P¼<0.0001) [Fig. 4
(B) and (C)]. On the other hand, the expression of ADAMTS-4
(P¼ 0.3918) and ADAMTS-9 (P¼ 0.781) was not inﬂuenced by
RUNX-2 siRNA [Supplemental Fig. 1(A) and (B)]. CTS-induced
MMP-13 and ADAMTS-5 (both P¼<0.0001) expressions were notdetected after RUNX-2 siRNA induction (MMP-13, P¼ 0.2949;
ADAMTS-5, P¼ 0.4065) [Fig. 4(B) and (C)]. The efﬁciency of RUNX-2
silencing by siRNA was conﬁrmed at the protein level by immu-
nocytochemistry. Expressions of RUNX-2, MMP-13 and ADAMTS-5
were down-regulated after siRUNX-2 transfection (Supplemental
Fig. 2, green signals).
Mechanical stretch increases the RUNX-2 and ADAMTS-5
expressions
Mechanical stretch changed the stress ﬁber formation in SW1353
cells (Fig. 5, red signals). However, the stress ﬁber orientations were
not parallel or perpendicular to the stretching direction. Expression
of RUNX-2 was up-regulated and localized in the nucleus following
CTS (Fig. 5, RUNX-2, green signals). On the other hand, expression of
ADAMTS-5wasup-regulated and localized in the cytoplasmafter CTS
(Fig. 5, ADAMTS-5, green signals). The percentage of RUNX-2 nuclear
translocation and ADAMTS-5 cytoplasmic location was 25 and 20%,
respectively.
Fig. 4. RUNX-2 siRNA inhibits MMP-13 and ADAMTS-5 gene expression in SW1353 cells. Results of real-time PCR analyses showed that relative RUNX-2 expression in SW1353 cells
was decreased by siRUNX-2 to 10% the level of non-transfected cells (A). RUNX-2 siRNA down-regulatedMMP-13 (B) and ADAMTS-5 (C) expression to 70% and 40%, respectively, the
level of non-transfected-cells. CTS-inducedMMP-13 and ADAMTS-5 expressions were not detected after RUNX-2 siRNA induction (B, C), n¼ 6 per experimental group. All genes were
normalized to G3PDH and plotted relative to CTS (), siRUNX-2 (). The data were presented as mean with 95% CI of triplicate determinations. *P< 0.0001, **P¼ 0.003.
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Phosphorylation of p38 at 60 min after CTS increased by 6.2 fold
compared to non-stretched controls (P¼<0.0001) [Fig. 6(A), upper
panel, (B)]. Phosphorylation of p44/42 and JNK was not increased
after CTS (P¼ 0.0741, 0.6616) [Fig. 6(A), middle and lower panel,
(B)]. This shows that CTS activates the p38 pathways in CTS-stim-
ulated SW1353 cells.
The effects of MAPK inhibitors on proteinase expression were
analyzed by real-time PCR. No obvious cytotoxic effect by these
inhibitors on SW1353 cells was observed. SB203580 down-regu-
lated CTS-induced RUNX-2 [Fig. 6(C), P¼<0.0001], MMP-13 [Fig. 6
(D), P¼<0.0001] and ADAMTS-5 [Figs. 6(E), P¼ 0.0152] expressions
in a dose-dependent manner. U0126 and JNK inhibitor II did not
inﬂuence RUNX-2, MMP-13 and ADAMTS-5 induction (data not
shown) (Fig. 7).
Discussion
Chondrocytes are highly responsive to mechanical compression
at both protein and gene transcript levels. In vivo, during normal
movement, articular chondrocytes experience compression loads
of 15%, which leads to 5% elongation of chondrocytes31. Although
chondrocytes are directly compressed during loading of intact
cartilage, it is very likely that collagen and other matrix compo-
nents of the ECM network, that are linked to the chondrocytes,
stretch the cells during compression of cartilage32. Previous studies
demonstrated that low magnitude mechanical strain results in up-
regulation of proteoglycan and type II collagen synthesis1,2,22. In
contrast, high magnitude mechanical strain initiates cartilage
destruction while inhibiting matrix synthesis33. Application of low
intensities of CTS (6%) consistently suppresses IL-1b-dependent NO
production, whereas higher intensity CTS fails to exert anti-
inﬂammatory effects22. It has been reported that CTS of low
magnitudes (4e8% equibiaxial strain) was a potent inhibitor of IL-
1b-dependent NK-kB nuclear translocation, whereas CTS of high
magnitudes (15e18% equibiaxial strain) mimicked the actions of
IL-1b and induced rapid nuclear translocation of NF-kB subunits
p64 and p5031. Not only magnitudes loaded to chondrocytes but
also frequency inﬂuences cell metabolism. Proteoglycan synthesiswas repressed by increasing the load frequency from 0.004 Hz to
0.5 Hz22. In the current study, expression of type II collagen was
reduced after 0.5 Hz, 10% CTS, not 5% CTS (Fig. 1), which suggests
that 10% CTS is a catabolic stimulus for SW1353 cells.
It is reported that under CTS (for 72 h, 10e30 cycles/min), cells
were aligned perpendicular to stretch direction in neonatal rat
cardiomyocytes34. However, cell orientation induced by CTS
change from parallel (stretch for 12 h) to perpendicular (stretch
for 24 h) to stretch direction35. After 2 h-CTS using ST-140, the
stress ﬁber orientations were not parallel, and not perpendicular,
to the stretch direction in human anterior cruciate ligament (ACL)
cells28. In the current study, we applied CTS to SW1353 cells for
30 min and did not ﬁnd the change of stress ﬁber orientations. It
was speculated that the duration of CTS applied to cells would
inﬂuence on stress ﬁber orientation.
It is clear that the protein catabolic enzymes such as MMPs and
ADAMTSs play key roles in the degradation of cartilage13,14. Among
the several aggrecanases identiﬁed, ADAMTS-4 and ADAMTS-5 are
the most efﬁcient in terms of their proteolytic activity, and there is
a general consensus that ADAMTS-4 and ADAMTS-5 play pivotal
roles in the pathogenesis of OA. Mice lacking ADAMTS-4 develop
cartilage degradation following surgical induction of joint insta-
bility in a similar manner to wild-type mice15. In contrast, gene
deletion of ADAMTS-5 protects mice from degradation by aggrecan
in surgically-induced OA13. Dual deletion of ADAMTS-4 and
ADAMTS-5 in mice provided protection against the cartilage
degradation in one study16, which was comparable to that of mice
with a single deletion of ADAMTS-5. These data suggest that
ADAMTS-5 might be the major aggrecanase, at least in the murine
model. In human OA cartilage, some reports suggested that
ADAMTS-4 might be a major aggrecanase in OA pathogenesis17.
ADAMTS-4 was predominantly expressed in an active form, and
chondrocyte immunoreactivity for ADAMTS-4 signiﬁcantly corre-
lated to the histological OA score, whereas ADAMTS-5 was consti-
tutively expressed in both OA and normal cartilage18. However,
suppression of ADAMTS-4 and ADAMTS-5 by transfection of siRNA,
individually or in combination, attenuated aggrecan degradation in
cytokine-treated human normal cartilage36. These ﬁndings suggest
that the dual inhibition of both ADAMTS-4 and ADAMTS-5might be
required for maximum drug efﬁcacy in the treatment of OA.
Fig. 5. Mechanical stretch modulates stress ﬁber formation and increases the expressions of RUNX-2 and ADAMTS-5 in SW1353 cells. Rearrangements of stress ﬁbers, detected by
phalloidin reagents, were induced by CTS (red signals). The expression of RUNX-2 was localized in the nucleus of SW1353 cells (RUNX-2, upper panel, green signals). The expression
of ADAMTS-5 was localized to the cytoplasm in SW1353 cells (ADAMTS-5, middle panel, green signals). Merged images are shown. Cells incubated in the absence of primary
antibodies were used as controls (lower panel). Arrows denote the direction of stretch. Stress ﬁbers were randomly aligned. Bar; 100 mm.
T. Tetsunaga et al. / Osteoarthritis and Cartilage 19 (2011) 222e232228Neither MMP nor ADAMTS inhibitor has a clear beneﬁcial effect
on OA, because of side effects such as ostealgia, myalgia, and
tendovaginitis37. Consequently, the upstream mechanisms of
these enzymes are potentially crucial subjects for the targeted
therapy of OA. RUNX-2 is an essential transcription factor in
osteoblast differentiation and bone formation23. The RUNX-2
binding site exists in the ADAMTS-4 and ADAMTS-5 promoter38,39,
suggesting that both ADAMTS-4 and ADAMTS-5 are potential
downstream targets of RUNX-2. In addition, RUNX-2 plays an
important role in cartilage matrix degradation24 by stimulatingthe expression of gene promoters related to MMP-1340. Runx-2
regulates the rat MMP-13 promoter, and it cooperates with the
AP-1 site to mediate MMP-13 transcription7. The results of
the present study demonstrate for the ﬁrst time that RUNX-2 is
the upstream regulator of mechanical stress-induced ADAMTS-5,
as well asMMP-13 gene expression, suggesting that RUNX-2 could
be a target gene in matrix degradation. This idea is partly sup-
ported by a previous report that Runx-2 mice were resistant to
instability-induced OA and had reduced type X and MMP-13
expression24.
Fig. 6. p38 MAPK modulated stretch-induced RUNX-2, MMP-13 and ADAMTS-5 induction. (A) The blots were probed for total p38, p44/42, JNK or phosphorylated p38 (p-p38), p44/
42 (p-p44/42), JNK (p-JNK). (B) Fold increase in phosphorylation (CTS:  vs þ) based on densitometric analyses of Western blots. Results of Western blotting and densitometric
analyses show the protein phosphorylation of p38, but not of p44/42 and JNK, in SW1353 cells after CTS for 30 min. Total protein extracts were subjected to PAGE (10 mg of total
protein/lane). SW1353 cells cultured in serum-free medium were pretreated with SB203580 for 30 min then stimulated with CTS for 30 min. Real-time PCR analyses showed that
the expression levels of RUNX-2 (C), MMP-13 (D) and ADAMTS-5 mRNA (E) were attenuated by SB203580 in a dose-dependent manner (n¼ 6 per experimental group). All genes
were normalized to G3PDH and plotted relative to CTS (), SB203580 (). The data were presented as mean with 95% CI of triplicate determinations. *P< 0.0001, **P¼ 0.0313,
yP¼ 0.0451, zP¼ 0.0152, xP¼ 0.0174 relative to TF ().
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p-38 MAPK
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Fig. 7. Possible signaling pathways involved in MMP-13 and collagenase gene regula-
tion by CTS in SW1353 cells. The mechanism of up-regulation of ADAMTS-4, -9
expressions by CTS was not investigated in the current study, but cytokines such as
IL-1might be involved in this process 20. Thick arrow; demonstrated in the current
study, thin arrow; demonstrated previously in the literature19,20,22,38,41,42,44e46,48,49.
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be differentially regulated41,42. ADAMTS-4 is inducible via
inﬂammatory cytokines such as IL-1b, TNFa, and TGF-b in chon-
drocytes and cartilage explants41,42. We have previously demon-
strated that the ADAMTS-9 gene is induced by IL-1b and TNFa20.
ADAMTS-9 appears to be more responsive to these pro-inﬂam-
matory cytokines than other aggrecanase genes. In the current
study, CTS up-regulated the expression of ADAMTS-4 and
ADAMTS-9, 24 h after CTS (Fig. 2). However, ADAMTS-4 and
ADAMTS-9 expression was not directly inﬂuenced by RUNX-2
overexpression or siRUNX-2. Although ADAMTS-4 and ADAMTS-9
up-regulation was induced by mechanical stress, these results
indicate that this up-regulation might be mediated by other than
RUNX-2, probably indirectly by CTS-induced cytokines, such as IL-
141. On the other hand, it is largely unknown how the activity of
ADAMTS-5 is modulated by mechanisms such as transcriptional
regulation or post-translational activation and/or processing in
chondrocytes. It is reported that mechanical injury of cartilage
T. Tetsunaga et al. / Osteoarthritis and Cartilage 19 (2011) 222e232230explants resulted in a ∼250-fold and ∼40-fold increase of MMP-3
and ADAMTS-5, respectively43. The transcription factor, c-fos and
c-jun, increased rapidly within the ﬁrst hour after injury, but
SOX9 did not respond43. Nevertheless, the effects of pro-inﬂam-
matory cytokines on ADAMTS-5 are also controversial. Previous
reports demonstrated synergistic induction from a combination of
IL-1b and oncostatin M for the ADAMTS-5 gene44. In the current
study, expression of the ADAMTS-5 gene following CTS showed
biphasic up-regulation. The earlier phase might be related to
mechanical stimuli through RUNX-2 up-regulation as shown by
RUNX-2 overexpression and siRUNX-2 transfection. As it has been
suggested that up-regulation of ADAMTS-4 induced by IL-1 or
TNFa is NF-kB dependent45, the mechanism by which NF-kB
interacts with the AP-1/RUNX-2 complex during ADAMTSs
up-regulation following mechanical stress requires further
investigation.
In the current study, we investigated the inhibitory effects of
MAPK on MMP-13 and ADAMTS-5 expression. CTS phosphorylated
p38 MAPK, which implies that CTS activates p38 pathways in
SW1353 cells. SB203580 dose-dependently attenuated the induc-
tion of RUNX-2, MMP-13 and ADAMTS-5 mRNA, with over 70%
reduction at a concentration of 10 mM. In the upstream mechanism
of RUNX-2-induced MMP-13 and ADAMTS-5 up-regulation, p38
might play a central role in response to CTS. A previous report that
RUNX-2 mediated the effects of p38 in the regulation of IL-1b-
induced MMP-13 expression in human articular chondrocytes
supports our ﬁndings46. In contrast, mechanical stress induces
RUNX-2 activation via a Ras/ERK1/2 dependent pathway, while
p38 up-regulation is independent of RUNX-2 activation in osteo-
blast-like MC3T3-E1 cells47. Cytokine-induced MMP-13 expression
requires activation of multiple MAPKs (ERK, p38 and/or JNK) in
human articular chondrocytes48 as well as bovine disc chon-
drocyte-like cells49. On the other hand, cytokine-induced MMP-13
expression requires activation of p38 only, not ERK or JNK in
chondrosarcoma cells46. In this study, MMP-13 and ADAMTS-5
expression was highly up-regulated by CTS-activated p38 only
(not ERK or JNK) which subsequently activated RUNX-2. This
discrepancy might be partly explained by different cell types and
mechanical stresses used in these in vitro experiments. The
cellular responses differed depending upon the types of
mechanical strain (tensile or compressive) applied27. Tensile stress
was more sensitive to, and had a stronger inﬂuence on, the acti-
vation of ERK, c-fos messenger RNA and c-Fos protein than
compressive stress in osteoblastic cells50. MMP-13 expression was
not affected by mechanical compression51,52, while CTS induced
MMP-13 expression25. Because other loading such as compression
might represent more physiological model, the results of the
current study using stretch simply represent experimental model
for OA. The RUNX-2 mediated pathways might be different if
studied in chondrocytes cultured under three-dimensional
condition, or by other mechanical loading system such as
compression.
In conclusion, the results of the current study demonstrate that
catabolic CTS-induced MMP-13 and ADAMTS-5 expressions were
regulated by RUNX-2 transcriptional factor via p38 MAPK pathway
in SW1353 cells. It is still unknown whether our results with
SW1353 chondrosarcoma cells which keep chondrocytic capability
in COL2A1 expression directly represent the biologic behavior of
human articular chondrocytes against mechanical stress. Chon-
drocytes cultured in such as alginate beads, which synthesize
a mechanically functional ECM or in vivo experiment using animal
model of OA to test the inhibition of RUNX-2 or p38 MAPK
inhibitor would provide further information to elucidate the
mechanism of aggrecan degradation in the course of cartilage
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